Myeloma proteins were characterized for heavy-chain and light-chain antigenic determinants by immune diffusion 8 and immunoelectrophoresis 9 with monospecifie antiserums. Patients receiving ...

The ability to eliminate specific pathologic cells is creating more options for multiple myeloma patients ... which is what makes the protein such a promising target, according to Shari Kaiser ...

Multiple myeloma can lower the numbers of these cells. Blood chemistry tests check levels of proteins and other substances in your blood. Multiple myeloma can cause high calcium levels and low ...

Response of myeloma to treatment was defined as ≥ 50% decrease of myeloma protein in the serum and ≥ 90% reduction of Bence-Jones proteinuria. Differences among various groups were compared ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

Previous studies revealed a positive correlation between O-GlcNAcylation and tumor growth via the stabilization of target proteins, with O-GlcNAcylation transferase (OGT) being the only enzyme capable ...

We do not know what causes MGUS. There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells.